A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

• Status: Completed
• Trial end date: 2000-11-01
• Target enrollment: 0
• Participant gender: All

Summary

A study of the ability of montelukast to improve signs and symptoms of seasonal allergic rhinitis compared with placebo. Loratadine is included in the study as an active control.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Loratadine; Montelukast

Criteria

Inclusion Criteria:

• Patient has a documented clinical history of seasonal allergic rhinitis symptoms that become worse during the study season

• Patient is a non-smoker

• Patient is in good mental and physical health

Exclusion Criteria:

• Patient is hospitalized

• Patient is a woman who is <8 weeks postpartum or is breast feeding

• Patient intends to move or vacation away during the study

• Patient is a current or past abuser of alcohol or illicit drugs